Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL
Surrogate Cardiometabolic Endpoints RCTs consistently demonstrate that combined SGLT2i and GLP-1RA therapy provides benefits in glycemic control, body weight, and blood pressure compared with either medication alone
Clarity prevents disappointment: players should always understand how to opt in or out and how each bonus interacts with their existing balance
Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control of type 2 diabetes
Prevention of chronic diseases like type 2 diabetes and heart disease could lead to substantial savings in healthcare costs
US$ 26.10
US$ 24.86
US$ 20.77
US$ 28.14
